Abstract:BACKGROUND AND AIM:Extensive research has revealed that microRNAs (miRNAs) play a principle role in cancer, and miRNAs associated with specific cancers have also been identified. The role of microRNA (miR)-302b-5p, which is one of the miRNAs reported in association with cancer, in hepatocellular carcinoma (HCC) is still unclear. Thus, the present study aimed to reveal the expression and potential molecule mechanism of miR-302b-5p in HCC.METHODS:An extensive meta-analysis of data from real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR), Gene Expression Omnibus and ArrayExpress microarrays was used to determine the expression of miR-302b-5p in HCC tissue samples and non-cancerous liver tissue samples. The sensitivity and specificity of miR-302b-5p as an indicator of HCC was estimated by plotting the receiver operating characteristic (ROC) and summarized ROC (sROC). Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were employed to unravel the molecular mechanisms and biological functions of miR-302b-5p in HCC. Further, the putative target genes of miR-302b-5p were harvested based on the predicted genes and differentially expressed genes in HCC. Finally, the protein-protein interaction (PPI) network was built to determine the hub genes.RESULTS:According to the RT-qPCR results, the expression of miR-302b-5p was pronouncedly decreased in 39 HCC tissue samples as compared to 39 non-cancerous liver tissue samples. The standard mean difference (SMD) values of all the samples used in the meta-analysis also indicated lower miR-302b-5p expression in the 558 HCC tissue samples than in the 286 non-cancerous liver tissue samples. ROC and sROC analyses showed that miR-302b-5p had good specificity and sensitivity for distinguishing HCC tissue from non-cancerous liver tissue. Bioinformatics analyses identified 227 putative genes, and these genes were evidently enriched in the processes of organelle fission, chromosome and chromatin binding and were centralized in a "lysosome" pathway. The PPI network indicated that DNA topoisomerase II alpha (TOP2 A) was the most prominent hub gene of miR-302b-5p in HCC. Interestingly, according to the TCGA and Genotype-Tissue Expression databases, the mRNA and protein expression of TOP2 A were both elevated in HCC tissue samples as compared to non-cancerous liver tissue samples, and the overall survival and disease-free survival revealed that a high level of TOP2 A might reflect poor HCC outcome.CONCLUSIONS:Our findings indicate that miR-302b-5p might suppress HCC progression, and TOP2 A might be a potential target of miR-302b-5p in HCC. However, in-depth in vivo and in vitro experiments are required to verify these findings and explore the mechanisms involved.

Expression And Potential Molecular Mechanisms Of Mir-204-5p In Breast Cancer, Based On Bioinformatics And A Meta-Analysis Of 2,306 Cases

Mir-143-5p Suppresses Breast Cancer Progression by Targeting the HIF-1-related GLUT1 Pathway

Tumor-promoting Properties of Mir-8084 in Breast Cancer Through Enhancing Proliferation, Suppressing Apoptosis and Inducing Epithelial–mesenchymal Transition

The Protective Value of Mir-204-5p for Prognosis and Its Potential Gene Network in Various Malignancies: a Comprehensive Exploration Based on RNA-seq High-Throughput Data and Bioinformatics.

Protective Potential of Mir-146A-5p and Its Underlying Molecular Mechanism in Diverse Cancers: a Comprehensive Meta-Analysis and Bioinformatics Analysis.

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

A Meta-Analysis And Bioinformatics Exploration Of The Diagnostic Value And Molecular Mechanism Of Mir-193a-5p In Lung Cancer

The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study.

MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.

MicroRNA-204 Inhibits the Proliferation and Metastasis of Breast Cancer Cells by Targeting PI3K/AKT Pathway.

Mir-204 Regulates the Biological Behavior of Breast Cancer MCF-7 Cells by Directly Targeting FOXA1

Clinical Value of Mir-101-3p and Biological Analysis of Its Prospective Targets in Breast Cancer: A Study Based on the Cancer Genome Atlas (TCGA) and Bioinformatics.

Mir-202 Acts As a Potential Tumor Suppressor in Breast Cancer

The Comprehensive Landscape of Mir-34A in Cancer Research

An Integrated Bioinformatics Analysis to Investigate the Targets of Mir-133A-1 in Breast Cancer

Identification of Exosomal Mir-455-5p and Mir-1255A As Therapeutic Targets for Breast Cancer

Role of MicroRNA-204 in Regulating the Hallmarks of Breast Cancer: An Update

Evaluation of Mir-302B-5p Expression and Molecular Mechanism in Hepatocellular Carcinoma: Findings Based on RT-qPCR and in Silico Analysis

A Comprehensive Investigation Using Meta-Analysis and Bioinformatics on Mir-34A-5p Expression and Its Potential Role in Head and Neck Squamous Cell Carcinoma.

Dynamically Decreased Mir-671-5p Expression is Associated with Oncogenic Transformation and Radiochemoresistance in Breast Cancer.

Downregulation of Mirna-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.